|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-2-18
|
|
pubmed:abstractText |
Common IL28B locus polymorphisms (SNPs rs8099917 and rs12979860) have been reported to affect peg-interferon plus ribavirin combination therapy (PEG-RBV) for hepatitis C virus (HCV) genotype 1b, but few reports have examined their effect on other two common genotypes, 2a and 2b.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
pubmed-author:AbeHiromiH,
pubmed-author:ChayamaKazuakiK,
pubmed-author:HayesC NelsonCN,
pubmed-author:HiragaNobuhikoN,
pubmed-author:ImamuraMichioM,
pubmed-author:KállayJJ,
pubmed-author:KawaokaTomokazuT,
pubmed-author:KuboMichakiM,
pubmed-author:KumadaHiromitsuH,
pubmed-author:MaekawaToshiroT,
pubmed-author:MitsuiFukikoF,
pubmed-author:NakamuraYusukeY,
pubmed-author:OchiHidenoriH,
pubmed-author:TakahashiShoichiS,
pubmed-author:TsugeMasatakaM,
pubmed-author:TsunodaTatsuhikoT
|
|
pubmed:copyrightInfo |
Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
408-14
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21112660-Aged,
pubmed-meshheading:21112660-Alleles,
pubmed-meshheading:21112660-Antiviral Agents,
pubmed-meshheading:21112660-Drug Resistance, Viral,
pubmed-meshheading:21112660-Female,
pubmed-meshheading:21112660-Gene Frequency,
pubmed-meshheading:21112660-Genotype,
pubmed-meshheading:21112660-Hepacivirus,
pubmed-meshheading:21112660-Hepatitis C, Chronic,
pubmed-meshheading:21112660-Humans,
pubmed-meshheading:21112660-Interferon Type I,
pubmed-meshheading:21112660-Interleukins,
pubmed-meshheading:21112660-Japan,
pubmed-meshheading:21112660-Male,
pubmed-meshheading:21112660-Middle Aged,
pubmed-meshheading:21112660-Polymorphism, Single Nucleotide,
pubmed-meshheading:21112660-RNA, Viral,
pubmed-meshheading:21112660-Recombinant Proteins,
pubmed-meshheading:21112660-Retrospective Studies,
pubmed-meshheading:21112660-Ribavirin,
pubmed-meshheading:21112660-Treatment Outcome,
pubmed-meshheading:21112660-Viral Load
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b.
|
|
pubmed:affiliation |
Laboratory for Digestive Diseases, Center for Genomic Medicine, RIKEN (The Institute of Physical and Chemical Research), 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
